Beneath the Surface: Moving Beyond Symptomatic Control in Obstructive Hypertrophic Cardiomyopathy
CMEO Webcast
Premiere Date: Wednesday, May 4, 2022This activity offers CE credit for:
- ABIM (MOC)
- Medicine (accme)
- Nursing (ANCC)
- Pharmacy (acpe)
- PA (aapa)
- Other
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date: Thursday, May 4, 2023
%>
Begin Activity Now
Faculty
![]() |
Theodore Abraham, MD, FACC (Moderator) Meyer Friedman Distinguished Professor of Medicine Co-Director, University of California at San Francisco HCM Center of Excellence San Francisco, CA |
![]() |
Steve R. Ommen, MD, FACC, FAHA Professor of Medicine, Mayo Clinic Director, Mayo Hypertrophic Cardiomyopathy Clinic Rochester, MN |
![]() |
Carolyn Yung Ho, MD Medical Director, Cardiovascular Genetics Center Cardiovascular Division, Brigham and Women's Hospital Harvard Medical School Boston, MA |
Statement of Need
Hypertrophic cardiomyopathy (HCM) is the most common monogenic cardiac disease, with a highly variable phenotypic expression that ranges from no symptoms to drug-refractory heart failure. HCM is a lifelong condition that can worsen over time and is characterized by ventricular hypertrophy that cannot be explained by another cardiac or systemic disease. Patients may go years without a diagnosis despite being symptomatic, putting them at increased risk for atrial fibrillation, stroke, heart failure, and sudden cardiac death.
To provide the best quality of care and achieve optimal outcomes, it is critical for clinicians to properly screen appropriate patients and determine the etiology of symptoms, which are often non-specific. Genetic testing can help determine if the hypertrophy is associated with mutations in one of several sarcomeric genes which encode components of the contractile apparatus of the heart.
In this CME Outfitters OnDemand symposium from Heart Rhythm 2022, three experts in HCM explore the latest strategies and updates in HCM diagnosis and management, including progress with disease-specific treatments that target cardiac myosin.
Learning Objectives
At the end of this CME/CE activity, participants should be able to:
%End>- Apply current, evidence-based diagnostic and treatment strategies to the care of patients with HCM.
- Assess the chemomechanical cycle of cardiac myosin in HCM and the impact of myosin inhibition on disease factors.
- Evaluate study results of disease-specific treatments targeting cardiac myosin in HCM.
Financial Support
Supported by an educational grant from Bristol Myers Squibb.
Target Audience
Physicians, PAs, nurse practitioners, nurses, and pharmacists specializing in cardiology and electrophysiology
Credit Information
Jointly Accredited Provider
In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians (ACCME):
CME Outfitters, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses (ANCC):
This activity is designated for 1.5 contact hours.
Note to Nurse Practitioners:
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.
California Residents:
This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.
Pharmacists (ACPE):
This application-based activity is approved for 1.5 contact hours (0.15 CEUs) of continuing pharmacy credit (JA0007185-0000-22-012-H01-P).
PAs (AAPA):
CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until 5/4/2023. PAs should only claim credit commensurate with the extent of their participation.
ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Learning Formats
Enduring activity
Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
MIPS Improvement Activity:
This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Dr. Abraham reports no financial relationships.
Dr. Ommen reports no financial relationships.
Dr. Ho reports the following financial relationships:
Advisory Board: Bristol Myers Squibb
Consultant: Tenaya Therapeutics
Research: Pfizer Inc.
The following peer reviewer and CME Outfitters staff report no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
This document was last modified on:
MMV-122-050422-08